Results 351 to 360 of about 570,531 (364)
Some of the next articles are maybe not open access.

Sonothrombolysis in Ischemic Stroke

Current Treatment Options in Neurology, 2013
Acute ischemic stroke remains one of the most devastating diseases when it comes to morbidity and mortality, not to mention the personal and economic burden that occurs in long-term. Intravenous thrombolysis with tissue plasminogen activator (tPA) is the only effective acute stroke therapy that improves outcome if given up to 4.5 hours from symptom ...
Andrei V. Alexandrov, Kristian Barlinn
openaire   +3 more sources

Ischemic Stroke Therapy

Annual Review of Medicine, 2002
▪ Abstract  Stroke is the most common life-threatening neurologic disease and the leading cause of serious long-term disability. The advent of new treatment options for selected patients suffering ischemic stroke (such as systemic administration of tissue plasminogen activator or catheter-guided intra-arterial thrombolysis), the structural ...
Jay P. Mohr, Christian Stapf
openaire   +3 more sources

Diagnosis of Ischemic Stroke

The American Journal of Medicine, 2009
Early stroke management, and early initiation of secondary stroke prevention, may improve outcomes in patients with acute ischemic stroke. However,
openaire   +3 more sources

Ischemic Strokes in Children

Journal of Child Neurology, 1986
Of 44 infants and children (neonates excluded) with ischemic strokes of arterial origin documented by CT scan and/or cerebral angiography, idiopathic strokes, occurring in 22 cases, accounted for half the total. Eight of these patients had basal ganglia and/or capsular infarcts without cortical involvement.
Françoise Goutières   +2 more
openaire   +3 more sources

Genetics of ischemic stroke

Current Opinion in Neurology, 1995
Advances in the study of cerebrovascular disease suggest that many risk factors for stroke are under genetic influence. Epidemiologic studies show that parental and sibling histories of cerebral ischemic events are associated with an increased risk of stroke.
Thomas J. DeGraba, LaRoy Penix
openaire   +3 more sources

Hypothermia and Ischemic Stroke

Current Treatment Options in Neurology, 2012
OPINION STATEMENT: The use of tissue plasminogen activator (tPA) is the major treatment method for acute ischemic stroke, but it reaches only a very limited number of stroke patients. Although neuroprotectants may be useful in stroke patients in principle, promising animal data have not yet been successfully transferred to stroke patients.
Stefan Schwab, Rainer Kollmar
openaire   +3 more sources

Epidemiology of Ischemic Stroke

Neurologic Clinics, 2016
Ischemic stroke is a heterogeneous multifactorial disorder recognized by the sudden onset of neurologic signs related directly to the sites of injury in the brain where the morbid process occurs. The evaluation of complex neurologic disorders, such as stroke, in which multiple genetic and epigenetic factors interact with environmental risk factors to ...
David S. Younger, Albert Favate
openaire   +3 more sources

Ischemic Stroke

Neuroimaging Clinics of North America, 2018
openaire   +2 more sources

Pediatric ischemic stroke

Journal of Neurology, 2020
Andrea Morotti   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy